Open Access

IGF2BP2‑dependent STIM1 inhibition protects against LPS‑induced pneumonia in vitro by alleviating endoplasmic reticulum stress and the inflammatory response

  • Authors:
    • Wei Zhou
    • Qigang Dai
    • Ning Su
    • Zhihui Liu
    • Jinxing Hu
  • View Affiliations

  • Published online on: October 26, 2023     https://doi.org/10.3892/etm.2023.12273
  • Article Number: 575
  • Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Pneumonia is a disease caused by inflammation and has high morbidity and mortality rates. Stromal interaction molecule 1 (STIM1) is involved in the regulation of inflammatory processes. However, to the best of the authors' knowledge, the role of STIM1 in pneumonia has not yet been reported. In the present study, lipopolysaccharide (LPS) was administered to A549 cells to construct a cell damage model. The expression of STIM1 in the model cells was detected by western blotting and reverse transcription‑quantitative PCR. Then, STIM1 expression was inhibited and cell survival was detected by Cell Counting Kit‑8 and flow cytometry. The expression of inflammatory factors was detected by enzyme‑linked immunosorbent assay and endoplasmic reticulum stress (ERS)‑related proteins were detected by immunofluorescence and western blotting. Subsequently, the relationship between insulin‑like growth factor 2 mRNA binding protein 2 (IGF2BP2) and STIM1 was verified by RNA‑binding protein immunoprecipitation assay and actinomycin D treatment. Finally, the regulatory mechanism of IGF2BP2 and STIM1 in LPS‑induced A549 cells was further investigated. The results of the present study demonstrated that STIM1 expression was increased in LPS‑induced A549 cells and that STIM1 knockdown inhibited LPS‑induced A549 cell apoptosis and alleviated LPS‑induced A549 cell inflammation and ERS. In addition, IGF2BP2 enhanced the stability of STIM1 mRNA and knockdown of IGF2BP2‑regulated STIM1 expression alleviated LPS‑induced ERS and inflammatory responses in A549 cells. In conclusion, knockdown of IGF2BP2‑regulated STIM1 improved cell damage in the LPS‑induced pneumonia cell model by alleviating ERS and the inflammatory response.
View Figures
View References

Related Articles

Journal Cover

December-2023
Volume 26 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhou W, Dai Q, Su N, Liu Z and Hu J: IGF2BP2‑dependent STIM1 inhibition protects against LPS‑induced pneumonia <em>in vitro</em> by alleviating endoplasmic reticulum stress and the inflammatory response. Exp Ther Med 26: 575, 2023
APA
Zhou, W., Dai, Q., Su, N., Liu, Z., & Hu, J. (2023). IGF2BP2‑dependent STIM1 inhibition protects against LPS‑induced pneumonia <em>in vitro</em> by alleviating endoplasmic reticulum stress and the inflammatory response. Experimental and Therapeutic Medicine, 26, 575. https://doi.org/10.3892/etm.2023.12273
MLA
Zhou, W., Dai, Q., Su, N., Liu, Z., Hu, J."IGF2BP2‑dependent STIM1 inhibition protects against LPS‑induced pneumonia <em>in vitro</em> by alleviating endoplasmic reticulum stress and the inflammatory response". Experimental and Therapeutic Medicine 26.6 (2023): 575.
Chicago
Zhou, W., Dai, Q., Su, N., Liu, Z., Hu, J."IGF2BP2‑dependent STIM1 inhibition protects against LPS‑induced pneumonia <em>in vitro</em> by alleviating endoplasmic reticulum stress and the inflammatory response". Experimental and Therapeutic Medicine 26, no. 6 (2023): 575. https://doi.org/10.3892/etm.2023.12273